RT Journal Article
SR Electronic
T1 Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.06.20050575
DO 10.1101/2020.04.06.20050575
A1 Sharon E. Fox
A1 Aibek Akmatbekov
A1 Jack L. Harbert
A1 Guang Li
A1 J. Quincy Brown
A1 Richard S. Vander Heide
YR 2020
UL http://medrxiv.org/content/early/2020/04/10/2020.04.06.20050575.abstract
AB SARS-CoV-2 has rapidly spread across the United States, causing extensive morbidity and mortality, though the histopathologic basis of severe disease cases has yet to be studied in detail. Over the past century, autopsy has contributed significantly to our understanding of numerous disease processes, but for several reasons, autopsy reports following deaths related to SARS- CoV-2 have thus far been limited across the globe. We report on the relevant cardiopulmonary findings in the first series of autopsies in the United States, with the cause of death being due to SARS-CoV-2 infection. These cases identify key pathologic states potentially contributing to severe disease and decompensation in these patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no payment or services from a third party for any aspect of the submitted work. No external funding was received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData presented within this manuscript is available upon request within applicable law.